XML 37 R27.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Note 8 - Noncontrolling Interest - Clyra Medical (Tables)
3 Months Ended
Mar. 31, 2024
Notes Tables  
Schedule of Other Ownership Interests [Table Text Block]
  

Clyra Options Outstanding

  Weighted average price per share  

Weighted average remaining life

 
Balance, December 31, 2022  1,583,329  $0.06     
Granted  42,582   1.48     
Balance, March 31, 2023  1,625,911  $0.09   7.5 
             

Balance, December 31, 2023

  1,478,922  $0.06     

Granted

  25,833  $4.05     

Balance, March 31, 2024

  1,504,755  $0.38   6.8 

Unvested

  (12,300) $2.71     

Balance, March 31, 2024

  1,492,455  $0.36   6.8 
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
  

2024

  

2023

 
  

Non Plan

  

2018 Plan

  

Non Plan

  

2018 Plan

 

Risk free interest rate

  %  4.16%  3.48%  3.48%

Expected volatility

  %  99%  114%  114%

Expected dividend yield

            

Forfeiture rate

            

Life in years

     10   10   10 
Warrants Outstanding for Noncontrolling Interest [Table Text Block]
   Clyra warrants outstanding  Weighted average price per share Weighted average remaining life 
Balance, December 31, 2022  207,513 $

3.72

   
Granted  72,581 $3.72   
Balance, March 31, 2023  280,094 $3.72 3.5
          
Balance, December 31, 2023  749,911 $3.74   
Granted  47,500 $7.50   
Balance, March 31, 2024  797,411 $3.96 2.7 
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]

Category

 

BioLargo

  

ONM

  

BLEST

  

Canada

  

BETI

  

BEST

  

Intercompany amounts

  

Totals

 

Accounts payable

 $200  $1,357  $62  $44  $24  $  $(24) $1,663 

Accrued payroll

  13   39   22         3      77 

Total

                             $1,740 

Category

 

BioLargo

  

ONM

  

BLEST

  

Canada

  

BETI

  

BEST

  

Intercompany amounts

  

Totals

 

Accounts payable

 $163  $964  $34  $93   40  $  $(82) $1,212 

Accrued payroll

  49   86   116               251 

Accrued interest

  25                     25 

Total

                             $1,488 
Clyra Medical [Member]  
Notes Tables  
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
  

March 31, 2024

  

December 31, 2023

 

Risk free interest rate

  4.16%  3.48 - 4.45%

Expected volatility

  49%  49%

Expected dividend yield

      

Forfeiture rate

      

Expected life in years

  10   10 
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]

Category

 

2024

  

2023

 

Accounts payable

 $417  $135 

Accrued dividend

  328  $242 

Accrued payroll

  12   7 

Accrued interest

  15   13 

Total

 $772  $397